The Business Research Company’s Fertility Treatments Global Market Report 2021: COVID 19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, August 23, 2021 /EINPresswire.com/ — Development of new techniques to treat infertility using a human’s body is a key trend in the fertility treatments market. INVOcell is an IVF alternative that uses the woman’s body to support fertilization, thus eliminating the cost of a laboratory incubator. The INVOcell device is placed with the eggs and sperm in the vaginal cavity, allowing for the stability of the natural environment, pH, and gas to help in fertilization. INVOcell, which is made in Medford, Massachusetts by INVO Bioscience, costs around $6,800 including medication. Although IVF generated more quality embryos, the birth rates between IVF and INVOcell are similar. According to the journal of assisted reproduction and genetics, 12 out of 20 women gave birth to 15 babies in IVF including three sets of twins and 11 out of 20 women gave birth to 16 babies in INVOcell group including five sets of twins.
The global fertility treatment market size is expected to grow from $14.27 billion in 2020 to $15.74 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The fertility treatments market is expected to reach $21.7 billion in 2025 at a CAGR of 8%.
Read More On The Global Fertility Treatments Market Report:
The fertility treatment market consists of sales services and related products that are used in various applications to treat infertile patients. Fertility treatment is a medical procedure intended to increase the chances of conceiving a child.
Major players in the fertility treatment industry are Apollo Hospitals Enterprise Ltd., Care Fertility Group, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Progyny Inc., Vitrolife, Carolinas Fertility Institute, and OvaScience Inc.
TBRC’s fertility treatment market report is segmented by product into reagents, equipment. The fertility treatment market is also segmented by end-user into fertility clinics, hospitals, surgical centers, clinical research institutes and by patient type into female, male.
Fertility Treatments Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides fertility treatments market overview, forecast fertility treatments market size and growth for the whole market, fertility treatments market segments, and geographies, fertility treatments market trends, fertility treatments market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Fertility Treatments Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Fertility Services Global Market Report 2021: COVID-19 Growth And Change To 2030
IVF Services Global Market Report 2021: COVID-19 Growth And Change To 2030
Genito-Urinary Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293